Verapido Medical GmbH is an innovative, clinical-stage medical device HSG-IMIT spinout company that develops, produces and markets innovative medical devices for injection and infusion of drugs and fluids into and under the skin. From Verapido's proprietary platform technology the company has developed an intradermal drug delivery device for drug targeting of the skin, immune and lymphatic system for vaccine, cosmetic, pharmaceutical and biotech companies that have a demand for intradermal drug delivery systems. Verapido’s product is unrivaled for certain applications and the only existing solution for intradermal delivery of large volumes and for long infusions. It is the only technology with a flat and long injection channel into the skin and is characterized by excellent sealing properties and low manufacturing costs. The company participates in the EXIST Transfer of Research grant program from the German Ministry of Economics and Technology.